| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c06bc0c2d1b16f9d16470b7e30874649 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-64 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K11-02 |
| filingDate |
2016-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b335eb76311eb92740a8978c7b352ee5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5e28c7a1c10ade9f1fd1d88b22c8fc3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdc4b6b88c8f99bd4c3b0b7ae618f2a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67ca4068e0e1c14a87e16fc2dd961581
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1981e470eb2527d184176908cf6ece0d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af95455f3d85b05ebf1b078866653248
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27df7f866eb58929a32fe68323ef9e51 |
| publicationDate |
2016-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2016354430-A1 |
| titleOfInvention |
Hexadepsipeptide analogues as anticancer compounds |
| abstract |
This invention relates to a method of treatment of cancer comprising administering compound of Formula (1) or derivatives or pharmaceutically acceptable salts thereof. |
| priorityDate |
2012-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |